I was also having a think about this:
" if I may c & p:
"There are many other gaps in our knowledge. How long does the vaccine provide protection without a booster? Does it affect natural immunity against HPV, and with what consequences? Can we really be sure that the vaccine protects preadolescent girls when proper clinical trials have been carried out only in women aged 16 to 24?
Another critical question is what vaccination does to the uptake of cervical screening. As the vaccines protect against only some of the cancer-causing strains, women must continue cervical screening. But vaccinated women may feel protected and therefore be less likely to go for screening.
Resolving these essential questions will require decades of observation of large numbers of women."
These are interesting and challenging questions - and as you say, research is "ongoing". They haven't yet been answered."
So here's an unanswred question. Can we really be sure that the vaccine protects preadolescent girls when proper clinical trials have been carried out only in women aged 16 to 24?
No, we can't. Equally, do we have some reason to be sure that it doesn't? Or do we even have any reason to believe that it does anything other than give protection against the virus? No, we don't. So what is the purpose of the question? Is it to add fog and confusion? Or it is demanding that we find a statistically significant sample of girls under 16, give half of then the jab and half not, and then expose them all to unprotected sex with a number of different partners? Almost certainly not. So, again, what is the constructive purpoise of this question? I can't see it. Can someone point it out to me in short clear sentences please?